Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
|---|---|---|---|---|---|---|---|---|---|---|---|
| N2586 | Tofacitinib | 0.3 | uM | 3 | IL-15 | 102.0 | 78 | ||||
| N2586 | IKK16 | 2.0 | uM | 3 | IL-15 | 115.5 | 58 | ||||
| N2586 | 3 | IL-15 | 117.0 | 44 | |||||||
| RA2159 | Visfatin | 1 | ng/mL | 3 | IL-15 | 100.5 | 56 | ||||
| RA2159 | PD184352 | 0.1 | uM | Visfatin | 1 | ng/mL | 3 | IL-15 | 128.0 | 41 | |
| RA2159 | Lestaurtinib | 0.3 | uM | Visfatin | 1 | ng/mL | 3 | IL-15 | 128.0 | 59 | |
| RA2159 | Ruxolitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 3 | IL-15 | 109.0 | 52 | |
| RA2159 | Tofacitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 3 | IL-15 | 103.5 | 58 | |
| RA2159 | IKK16 | 2.0 | uM | Visfatin | 1 | ng/mL | 3 | IL-15 | 129.0 | 53 | |
| N2586 | Visfatin | 1 | ng/mL | 3 | IL-15 | 117.5 | 56 | ||||
| N2586 | PD184352 | 0.1 | uM | Visfatin | 1 | ng/mL | 3 | IL-15 | 123.5 | 60 | |
| N2586 | Lestaurtinib | 0.3 | uM | Visfatin | 1 | ng/mL | 3 | IL-15 | 119.0 | 71 | |
| N2586 | Ruxolitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 3 | IL-15 | 138.0 | 43 | |
| N2586 | Tofacitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 3 | IL-15 | 84.5 | 62 | |
| N2586 | IKK16 | 2.0 | uM | Visfatin | 1 | ng/mL | 3 | IL-15 | 125.0 | 51 | |
| RA2159 | Leptin | 1 | ng/mL | 3 | IL-15 | 116.0 | 71 | ||||
| RA2159 | PD184352 | 0.1 | uM | Leptin | 1 | ng/mL | 3 | IL-15 | 116.5 | 66 | |
| RA2159 | Lestaurtinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | IL-15 | 87.0 | 66 | |
| RA2159 | Ruxolitinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | IL-15 | 119.0 | 69 | |
| RA2159 | Tofacitinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | IL-15 | 113.0 | 59 | |
| RA2159 | IKK16 | 2.0 | uM | Leptin | 1 | ng/mL | 3 | IL-15 | 130.0 | 55 | |
| N2586 | Leptin | 1 | ng/mL | 3 | IL-15 | 116.5 | 64 | ||||
| N2586 | PD184352 | 0.1 | uM | Leptin | 1 | ng/mL | 3 | IL-15 | 124.0 | 73 | |
| N2586 | Lestaurtinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | IL-15 | 111.0 | 56 | |
| N2586 | Ruxolitinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | IL-15 | 117.0 | 86 |